{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T22:01:05Z","timestamp":1790892065603,"version":"4.1.0"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,12,2]],"date-time":"2021-12-02T00:00:00Z","timestamp":1638403200000},"content-version":"vor","delay-in-days":1,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Cancer"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Non-small cell lung cancer (NSCLC) is the most common type of human lung cancers, which has diverse pathological features. Although many signaling pathways and therapeutic targets have been defined to play important roles in NSCLC, limiting efficacies have been achieved.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Bioinformatics methods were used to identify differential long non-coding RNA expression in NSCLC. Real-time RT-PCR experiments were used to examine the expression pattern of lncRNA PKMYT1AR, miR-485-5p. Both in vitro and in vivo functional assays were performed to investigate the functional role of PKMYT1AR\/miR-485-5p\/PKMYT1 axis on regulating cell proliferation, migration and tumor growth. Dual luciferase reporter assay, fluorescent in situ hybridization (FISH), immunoblot, co-immunoprecipitation experiments were used to verify the molecular mechanism.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Result<\/jats:title>\n                    <jats:p>Here, we identify a human-specific long non-coding RNA (lncRNA, ENST00000595422), termed PKMYT1AR (PKMYT1 associated lncRNA), that is induced in NSCLC by Yin Yang 1 (YY1) factor, especially in cancerous cell lines (H358, H1975, H1299, H1650, A549 and SPC-A1) compared to that in normal human bronchial epithelium cell line (BEAS-2B). We show that PKMYT1AR high expression correlates with worse clinical outcome, and knockdown of PKMYT1AR inhibits tumor cell proliferation, migration and xenograft tumor formation abilities. Bioinformatic analysis and a luciferase assay demonstrate that PKMYT1AR directly interacts with miR-485-5p to attenuate the inhibitory role on its downstream oncogenic factor PKMYT1 (the protein kinase, membrane-associated tyrosine\/threonine 1) in NSCLC. Furthermore, we uncover that miR-485-5p is downregulated in both cancerous cell lines and peripheral blood serum isolated from NSCLC patients compared to reciprocal control groups. Consistently, forced expression of miR-485-5p inhibits the proliferation and migration abilities of tumor cells. Moreover, we provide evidence showing that PKMYT1AR targeting antisense oligonucleotide (ASO) dramatically inhibit tumor growth in vivo. Mechanistic study shows that PKMYT1AR\/ miR-485-5p \/PKMYT1 axis promotes cancer stem cells (CSCs) maintenance in NSCLC via inhibiting \u03b2-TrCP1 mediated ubiquitin degradation of \u03b2-catenin proteins, which in turn causes enhanced tumorigenesis.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Our findings reveal the critical role of PKMYT1AR\/miR-485-5p \/PKMYT1 axis during NSCLC progression, which could be used as novel therapeutic targets in the future.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12943-021-01469-6","type":"journal-article","created":{"date-parts":[[2021,12,2]],"date-time":"2021-12-02T02:03:29Z","timestamp":1638410609000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":131,"title":["LncRNA PKMYT1AR promotes cancer stem cell maintenance in non-small cell lung cancer via activating Wnt signaling pathway"],"prefix":"10.1186","volume":"20","author":[{"given":"Yaomei","family":"He","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiulin","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lincan","family":"Duan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiuxia","family":"Xiong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yixiao","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peishen","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liping","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiushuo","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Song","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cuiping","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6534-6991","authenticated-orcid":false,"given":"Yongbin","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,12,2]]},"reference":[{"key":"1469_CR1","doi-asserted-by":"publisher","first-page":"1243","DOI":"10.1097\/JTO.0000000000000630","volume":"10","author":"WD Travis","year":"2015","unstructured":"Travis WD, Brambilla E, Nicholson AG, Yatabe Y, Austin JHM, Beasley MB, et al. The 2015 World Health Organization classification of lung tumors: impact of genetic, clinical and radiologic advances since the 2004 classification. J Thorac Oncol. 2015;10:1243\u201360.","journal-title":"J Thorac Oncol"},{"key":"1469_CR2","doi-asserted-by":"publisher","first-page":"223","DOI":"10.5301\/tj.5000479","volume":"2016","author":"G Lo Russo","year":"2016","unstructured":"Lo Russo G, Imbimbo M, Garassino MC. Is the chemotherapy era in advanced non-small cell lung cancer really over? Maybe not yet. Tumori. 2016;2016:223\u20135.","journal-title":"Tumori"},{"key":"1469_CR3","doi-asserted-by":"publisher","first-page":"271","DOI":"10.3322\/caac.21349","volume":"66","author":"KD Miller","year":"2016","unstructured":"Miller KD, Siegel RL, Lin CC, Mariotto AB, Kramer JL, Rowland JH, et al. Cancer treatment and survivorship statistics, 2016. CA Cancer J Clin. 2016;66:271\u201389.","journal-title":"CA Cancer J Clin"},{"key":"1469_CR4","first-page":"57","volume":"394","author":"A Roth","year":"2016","unstructured":"Roth A, Diederichs S. Long noncoding RNAs in lung cancer. Long non-coding Rnas in human disease. Curr Top Microbiol Immunol. 2016;394:57\u2013110.","journal-title":"Curr Top Microbiol Immunol"},{"key":"1469_CR5","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1016\/j.cell.2018.01.011","volume":"172","author":"F Kopp","year":"2018","unstructured":"Kopp F, Mendell JT. Functional classification and experimental dissection of long noncoding RNAs. Cell. 2018;172:393\u2013407.","journal-title":"Cell"},{"key":"1469_CR6","first-page":"3046379","volume":"2019","author":"SS Lee","year":"2019","unstructured":"Lee SS, Cheah YK. The Interplay between MicroRNAs and cellular components of tumour microenvironment (TME) on non-small-cell lung cancer (NSCLC) progression. J Immunol Res. 2019;2019:3046379.","journal-title":"J Immunol Res"},{"key":"1469_CR7","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/j.gendis.2014.06.004","volume":"1","author":"C Price","year":"2014","unstructured":"Price C, Chen J. MicroRNAs in cancer biology and therapy: current status and perspectives. Genes Dis. 2014;1:53\u201363.","journal-title":"Genes Dis"},{"key":"1469_CR8","doi-asserted-by":"publisher","first-page":"1895","DOI":"10.1016\/j.biocel.2013.05.030","volume":"45","author":"CH Li","year":"2013","unstructured":"Li CH, Chen YC. Targeting long non-coding RNAs in cancers: progress and prospects. Int J Biochem Cell Biol. 2013;45:1895\u2013910.","journal-title":"Int J Biochem Cell Biol"},{"key":"1469_CR9","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/j.addr.2014.11.014","volume":"81","author":"M Garofalo","year":"2015","unstructured":"Garofalo M, Croce CM. Role of microRNAs in maintaining cancer stem cells. Adv Drug Deliv Rev. 2015;81:53\u201361.","journal-title":"Adv Drug Deliv Rev"},{"key":"1469_CR10","doi-asserted-by":"publisher","first-page":"7384","DOI":"10.7150\/thno.37892","volume":"9","author":"TT Tang","year":"2019","unstructured":"Tang TT, Guo CY, Xia TS, Zhang R, Zen K, Pan Y, et al. LncCCAT1 promotes breast cancer stem cell function through activating WNT\/beta-catenin signaling. Theranostics. 2019;9:7384\u2013402.","journal-title":"Theranostics"},{"key":"1469_CR11","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/j.pharmthera.2015.12.001","volume":"158","author":"G Leon","year":"2016","unstructured":"Leon G, MacDonagh L, Finn SP, Cuffe S, Barr MP. Cancer stem cells in drug resistant lung cancer: targeting cell surface markers and signaling pathways. Pharmacol Ther. 2016;158:71\u201390.","journal-title":"Pharmacol Ther"},{"key":"1469_CR12","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1016\/0092-8674(87)90458-2","volume":"49","author":"P Russell","year":"1987","unstructured":"Russell P, Nurse P. Negative regulation of mitosis by wee1+, a gene encoding a protein-kinase homolog. Cell. 1987;49:559\u201367.","journal-title":"Cell"},{"key":"1469_CR13","doi-asserted-by":"publisher","first-page":"2425","DOI":"10.1016\/j.celrep.2015.11.021","volume":"13","author":"CM Toledo","year":"2015","unstructured":"Toledo CM, Ding Y, Hoellerbauer P, Davis RJ, Basom R, Girard EJ, et al. Genome-wide CRISPR-Cas9 screens reveal loss of redundancy between PKMYT1 and WEE1 in glioblastoma stem-like cells. Cell Rep. 2015;13:2425\u201339.","journal-title":"Cell Rep"},{"key":"1469_CR14","first-page":"4210","volume":"23","author":"QS Sun","year":"2019","unstructured":"Sun QS, Luo M, Zhao HM, Sun H. Overexpression of PKMYT1 indicates the poor prognosis and enhances proliferation and tumorigenesis in non-small cell lung cancer via activation of Notch signal pathway. Eur Rev Med Pharmacol Sci. 2019;23:4210\u20139.","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"1469_CR15","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1016\/j.yexcr.2017.06.014","volume":"358","author":"L Liu","year":"2017","unstructured":"Liu L, Wu JS, Wang SC, Luo XL, Du YM, Huang DF, et al. PKMYT1 promoted the growth and motility of hepatocellular carcinoma cells by activating beta-catenin\/TCF signaling. Exp Cell Res. 2017;358:209\u201316.","journal-title":"Exp Cell Res"},{"key":"1469_CR16","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1038\/s41392-021-00555-x","volume":"6","author":"Q Xiong","year":"2021","unstructured":"Xiong Q, Jiang L, Liu K, Jiang X, Liu B, Shi Y, et al. miR-133b targets NCAPH to promote \u03b2-catenin degradation and reduce cancer stem cell maintenance in non-small cell lung cancer. Signal Transduct Target Ther. 2021;6:252.","journal-title":"Signal Transduct Target Ther"},{"key":"1469_CR17","doi-asserted-by":"publisher","first-page":"D991","DOI":"10.1093\/nar\/gks1193","volume":"41","author":"T Barrett","year":"2013","unstructured":"Barrett T, Wilhite SE, Ledoux P, Evangelista C, Kim IF, Tomashevsky M, et al. NCBI GEO: archive for functional genomics data sets-update. Nucleic Acids Res. 2013;41:D991\u20135.","journal-title":"Nucleic Acids Res"},{"key":"1469_CR18","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1016\/j.ccell.2020.04.012","volume":"37","author":"J Carrot-Zhang","year":"2020","unstructured":"Carrot-Zhang J, Chambwe N, Damrauer JS, Knijnenburg TA, Robertson AG, Yau C, et al. Comprehensive analysis of genetic ancestry and its molecular correlates in cancer. Cancer Cell. 2020;37:639.","journal-title":"Cancer Cell"},{"key":"1469_CR19","doi-asserted-by":"publisher","first-page":"D92","DOI":"10.1093\/nar\/gkt1248","volume":"42","author":"JH Li","year":"2014","unstructured":"Li JH, Liu S, Zhou H, Qu LH, Yang JH. starBase v2.0: decoding miRNA-ceRNA, miRNA-ncRNA and protein-RNA interaction networks from large-scale CLIP-Seq data. Nucleic Acids Res. 2014;42:D92\u20137.","journal-title":"Nucleic Acids Res"},{"key":"1469_CR20","doi-asserted-by":"publisher","first-page":"W98","DOI":"10.1093\/nar\/gkx247","volume":"45","author":"ZF Tang","year":"2017","unstructured":"Tang ZF, Li CW, Kang BX, Gao G, Li C, Zhang ZM. GEPIA: a web server for cancer and normal gene expression profiling and interactive analyses. Nucleic Acids Res. 2017;45:W98\u2013W102.","journal-title":"Nucleic Acids Res"},{"key":"1469_CR21","first-page":"1","volume":"8","author":"A Nagy","year":"2018","unstructured":"Nagy A, Lanczky A, Menyhart O, Gyorffy B. Validation of miRNA prognostic power in hepatocellular carcinoma using expression data of independent datasets (vol 8, 9227, 2018). Sci Rep. 2018;8:1\u20139.","journal-title":"Sci Rep"},{"key":"1469_CR22","doi-asserted-by":"publisher","first-page":"15545","DOI":"10.1073\/pnas.0506580102","volume":"102","author":"A Subramanian","year":"2005","unstructured":"Subramanian A, Tamayo P, Mootha VK, Mukherjee S, Ebert BL, Gillette MA, et al. Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc Natl Acad Sci U S A. 2005;102:15545\u201350.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"1469_CR23","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1186\/s12943-017-0674-z","volume":"16","author":"J Jen","year":"2017","unstructured":"Jen J, Tang YA, Lu YH, Lin CC, Lai WW, Wang YC. Oct4 transcriptionally regulates the expression of long non-coding RNAs NEAT1 and MALAT1 to promote lung cancer progression. Mol Cancer. 2017;16:104.","journal-title":"Mol Cancer"},{"key":"1469_CR24","first-page":"8403","volume":"23","author":"PF Yu","year":"2019","unstructured":"Yu PF, Wang Y, Lv W, Kou D, Hu HL, Guo SS, et al. LncRNA NEAT1\/miR-1224\/KLF3 contributes to cell proliferation, apoptosis and invasion in lung cancer. Eur Rev Med Pharmacol Sci. 2019;23:8403\u201310.","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"1469_CR25","doi-asserted-by":"publisher","first-page":"11729","DOI":"10.2147\/OTT.S214049","volume":"12","author":"ZB Wang","year":"2019","unstructured":"Wang ZB, Zhang HY, Lu JB. Expression and effects of long non-coding RNA, LINC01124, in non-small cell lung cancer. Onco Targets Ther. 2019;12:11729\u201336.","journal-title":"Onco Targets Ther"},{"key":"1469_CR26","doi-asserted-by":"publisher","first-page":"682","DOI":"10.1101\/gr.238733.118","volume":"29","author":"Y Shao","year":"2019","unstructured":"Shao Y, Chen C, Shen H, He BZ, Yu D, Jiang S, et al. GenTree, an integrated resource for analyzing the evolution and function of primate-specific coding genes. Genome Res. 2019;29:682\u201396.","journal-title":"Genome Res"},{"key":"1469_CR27","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1002\/path.5026","volume":"244","author":"A Mezheyeuski","year":"2018","unstructured":"Mezheyeuski A, Bergsland CH, Backman M, Djureinovic D, Sj\u00f6blom T, Bruun J, et al. Multispectral imaging for quantitative and compartment-specific immune infiltrates reveals distinct immune profiles that classify lung cancer patients. J Pathol. 2018;244:421\u201331.","journal-title":"J Pathol"},{"key":"1469_CR28","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1016\/j.canlet.2008.02.010","volume":"265","author":"SC Yu","year":"2008","unstructured":"Yu SC, Ping YF, Yi L, Zhou ZH, Chen JH, Yao XH, et al. Isolation and characterization of cancer stem cells from a human glioblastoma cell line U87. Cancer Lett. 2008;265:124\u201334.","journal-title":"Cancer Lett"},{"key":"1469_CR29","doi-asserted-by":"crossref","unstructured":"Lin Y, Pan X, Shen HB. lncLocator 2.0: a cell-line-specific subcellular localization predictor for long non-coding RNAs with interpretable deep learning. Bioinformatics. 2021.","DOI":"10.1093\/bioinformatics\/btab127"},{"key":"1469_CR30","doi-asserted-by":"publisher","first-page":"D87","DOI":"10.1093\/nar\/gkaa516","volume":"48","author":"O Fornes","year":"2020","unstructured":"Fornes O, Castro-Mondragon JA, Khan A, van der Lee R, Zhang X, Richmond PA, et al. JASPAR 2020: update of the open-access database of transcription factor binding profiles. Nucleic Acids Res. 2020;48:D87\u2013d92.","journal-title":"Nucleic Acids Res"},{"key":"1469_CR31","doi-asserted-by":"publisher","first-page":"3651","DOI":"10.1093\/nar\/gkg605","volume":"31","author":"D Farr\u00e9","year":"2003","unstructured":"Farr\u00e9 D, Roset R, Huerta M, Adsuara JE, Rosell\u00f3 L, Alb\u00e0 MM, et al. Identification of patterns in biological sequences at the ALGGEN server: PROMO and MALGEN. Nucleic Acids Res. 2003;31:3651\u20133.","journal-title":"Nucleic Acids Res"},{"key":"1469_CR32","doi-asserted-by":"publisher","first-page":"2258","DOI":"10.1002\/jcb.29448","volume":"121","author":"X Li","year":"2020","unstructured":"Li X, Yu M, Yang C. YY1-mediated overexpression of long noncoding RNA MCM3AP-AS1 accelerates angiogenesis and progression in lung cancer by targeting miR-340-5p\/KPNA4 axis. J Cell Biochem. 2020;121:2258\u201367.","journal-title":"J Cell Biochem"},{"key":"1469_CR33","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1007\/s10549-009-0674-9","volume":"123","author":"B Gyorffy","year":"2010","unstructured":"Gyorffy B, Lanczky A, Eklund AC, Denkert C, Budczies J, Li Q, et al. An online survival analysis tool to rapidly assess the effect of 22,277 genes on breast cancer prognosis using microarray data of 1,809 patients. Breast Cancer Res Treat. 2010;123:725\u201331.","journal-title":"Breast Cancer Res Treat"},{"key":"1469_CR34","doi-asserted-by":"crossref","unstructured":"Agarwal V, Bell GW, Nam JW, Bartel DP. Predicting effective microRNA target sites in mammalian mRNAs. Elife. 2015;4.","DOI":"10.7554\/eLife.05005"},{"key":"1469_CR35","doi-asserted-by":"publisher","first-page":"710","DOI":"10.1136\/jmedgenet-2015-103334","volume":"52","author":"X Qi","year":"2015","unstructured":"Qi X, Zhang DH, Wu N, Xiao JH, Wang X, Ma W. ceRNA in cancer: possible functions and clinical implications. J Med Genet. 2015;52:710\u20138.","journal-title":"J Med Genet"},{"key":"1469_CR36","doi-asserted-by":"publisher","first-page":"376","DOI":"10.3389\/fgene.2020.00376","volume":"11","author":"HP Long","year":"2020","unstructured":"Long HP, Liu JQ, Yu YY, Qiao Q, Li G. PKMYT1 as a potential target to improve the radiosensitivity of lung adenocarcinoma. Front Genet. 2020;11:376.","journal-title":"Front Genet"},{"key":"1469_CR37","doi-asserted-by":"crossref","unstructured":"Yang XW, Yang CP, Jiang LP, Qin XJ, Liu YP, Shen QS, et al. Indole alkaloids with new skeleton activating neural stem cells. Org Lett. 2014.","DOI":"10.1021\/ol5029223"},{"key":"1469_CR38","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1080\/1061186X.2018.1479756","volume":"27","author":"A Barzegar Behrooz","year":"2019","unstructured":"Barzegar Behrooz A, Syahir A, Ahmad S. CD133: beyond a cancer stem cell biomarker. J Drug Target. 2019;27:257\u201369.","journal-title":"J Drug Target"},{"key":"1469_CR39","doi-asserted-by":"publisher","first-page":"a007898","DOI":"10.1101\/cshperspect.a007898","volume":"5","author":"JL Stamos","year":"2013","unstructured":"Stamos JL, Weis WI. The beta-catenin destruction complex. Cold Spring Harb Perspect Biol. 2013;5:a007898.","journal-title":"Cold Spring Harb Perspect Biol"},{"key":"1469_CR40","doi-asserted-by":"publisher","first-page":"e08022","DOI":"10.7554\/eLife.08022","volume":"4","author":"MI Pronobis","year":"2015","unstructured":"Pronobis MI, Rusan NM, Peifer M. A novel GSK3-regulated APC:Axin interaction regulates Wnt signaling by driving a catalytic cycle of efficient \u03b2catenin destruction. Elife. 2015;4:e08022.","journal-title":"Elife"},{"key":"1469_CR41","doi-asserted-by":"publisher","first-page":"13616","DOI":"10.1038\/ncomms13616","volume":"7","author":"K Katsushima","year":"2016","unstructured":"Katsushima K, Natsume A, Ohka F, Shinjo K, Hatanaka A, Ichimura N, et al. Targeting the Notch-regulated non-coding RNA TUG1 for glioma treatment. Nat Commun. 2016;7:13616.","journal-title":"Nat Commun"},{"key":"1469_CR42","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1620\/tjem.246.107","volume":"246","author":"MC Negrete-Garcia","year":"2018","unstructured":"Negrete-Garcia MC, Ramirez-Rodrigue SL, Rangel-Escareno C, Munoz-Montero S, Kelly-Garcia J, Vazquez-Manriquez ME, et al. Deregulated MicroRNAs in cancer-associated fibroblasts from front tumor tissues of lung adenocarcinoma as potential predictors of tumor promotion. Tohoku J Exp Med. 2018;246:107\u201320.","journal-title":"Tohoku J Exp Med"},{"key":"1469_CR43","doi-asserted-by":"crossref","unstructured":"Zhao R, Shan Y, Zhou X, Zhang C, Zhao R, Zhao L, et al. MicroRNA-485-5p suppresses the progression of esophageal squamous cell carcinoma by targeting flotillin-1 and inhibits the epithelial-mesenchymal transition. Oncol Rep. 2021;45.","DOI":"10.3892\/or.2021.8044"},{"key":"1469_CR44","doi-asserted-by":"publisher","first-page":"e2159","DOI":"10.1038\/cddis.2016.27","volume":"7","author":"C Lou","year":"2016","unstructured":"Lou C, Xiao M, Cheng S, Lu X, Jia S, Ren Y, et al. MiR-485-3p and miR-485-5p suppress breast cancer cell metastasis by inhibiting PGC-1\u03b1 expression. Cell Death Dis. 2016;7:e2159.","journal-title":"Cell Death Dis"},{"key":"1469_CR45","doi-asserted-by":"publisher","first-page":"4778","DOI":"10.1038\/onc.2012.504","volume":"32","author":"JPH Chow","year":"2013","unstructured":"Chow JPH, Poon RYC. The CDK1 inhibitory kinase MYT1 in DNA damage checkpoint recovery. Oncogene. 2013;32:4778\u201388.","journal-title":"Oncogene"},{"key":"1469_CR46","first-page":"2829","volume":"39","author":"D Jeong","year":"2018","unstructured":"Jeong D, Kim H, Kim D, Ban S, Oh S, Ji S, et al. Protein kinase, membrane-associated tyrosine\/threonine 1 is associated with the progression of colorectal cancer. Oncol Rep. 2018;39:2829\u201336.","journal-title":"Oncol Rep"},{"key":"1469_CR47","doi-asserted-by":"crossref","unstructured":"Schmidt M, Rohe A, Platzer C, Najjar A, Erdmann F, Sippl W. Regulation of G2\/M Transition by Inhibition of WEE1 and PKMYT1 Kinases. Molecules. 2017;22.","DOI":"10.3390\/molecules22122045"},{"key":"1469_CR48","doi-asserted-by":"publisher","first-page":"79515","DOI":"10.18632\/oncotarget.12819","volume":"7","author":"B Yang","year":"2016","unstructured":"Yang B, Zhang S, Wang Z, Yang C, Ouyang W, Zhou F, et al. Deubiquitinase USP9X deubiquitinates \u03b2-catenin and promotes high grade glioma cell growth. Oncotarget. 2016;7:79515\u201325.","journal-title":"Oncotarget"}],"container-title":["Molecular Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12943-021-01469-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12943-021-01469-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12943-021-01469-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,4,18]],"date-time":"2022-04-18T09:11:35Z","timestamp":1650273095000},"score":1,"resource":{"primary":{"URL":"https:\/\/molecular-cancer.biomedcentral.com\/articles\/10.1186\/s12943-021-01469-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,12]]},"references-count":48,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["1469"],"URL":"https:\/\/doi.org\/10.1186\/s12943-021-01469-6","relation":{},"ISSN":["1476-4598"],"issn-type":[{"value":"1476-4598","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,12]]},"assertion":[{"value":"6 September 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 November 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 December 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the Ethics Committee of Kunming Institute of Zoology, Chinese Academy of Sciences (CAS). Clinical samples were obtained with informed consent and all protocols were approved by The Second Xiangya Hospital of Central South University Ethics Review Board (Scientific and Research Ethics Committee, S-02\/2000).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare have no conflict of interest.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"156"}}